PROVIDER PROFILE · NPI 1508866567

Bhupendra ToliaM.D.

UrologyBronx, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

482

Unique beneficiaries

—

Total services

678

Distinct HCPCS

Medicare payment

$32K

Peer benchmark

Total Medicare services vs. 756 Urology providers in NY — below median (cohort median 1,574).

PRESCRIBING · PART D · 2024

Total Rx claims

1,220

Beneficiaries

—

Total drug cost

$856K

Distinct drugs

Brand share

41.5%

Top prescribed drugs

Tamsulosin Hcl370 claims

Nitrofurantoin Monohyd/M-Cryst183 claims

Finasteride181 claims

Vibegron82 claims

Oxybutynin Chloride55 claims

QUALITY · MIPS · 2024

Final MIPS score

100.0

Quality

15.8

Cost

75.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

1.05%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$778

Payment records

By payment type

Food and Beverage$653

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$125

REFERRAL NETWORK

Where Bhupendra Tolia's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Neogenomics Laboratories Inc Clinical Laboratory · Ramsey, NJ	35	80
Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ	25	52
David Noble Diagnostic Radiology · Bronx, NY	18	29

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history